Survival-associated factors of first-line EGFR-tyrosine kinase inhibitor responders and non-responders in lung adenocarcinoma patients with common EGFR mutations

The aim of the present retrospective cohort study was to elucidate the clinical presentation of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) responders and non-responders in lung adenocarcinoma patients with common EGFR mutations. The cohort included 131 lung adenocarcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Ming-Szu, Fang, Yu-Hung, Lin, Yu-Ching, Lung, Jr-Hau, Hsieh, Meng-Jer, Tsai, Ying-Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795572/
https://www.ncbi.nlm.nih.gov/pubmed/29456848
http://dx.doi.org/10.3892/mco.2018.1550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795572/
https://www.ncbi.nlm.nih.gov/pubmed/29456848
http://dx.doi.org/10.3892/mco.2018.1550

Ejemplares similares